|Bid||108.76 x 800|
|Ask||109.27 x 800|
|Day's range||107.09 - 110.51|
|52-week range||69.74 - 126.53|
|Beta (5Y monthly)||1.90|
|PE ratio (TTM)||N/A|
|Earnings date||03 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||121.00|
No stock is completely hidden away, of course. To be sure, there are less-trumpeted stocks that you shouldn't buy. Cresco Labs (OTC: CRLBF) doesn't receive as much attention as it deserves, in my opinion.
Resilient stocks hold up well during a recession, and these three stocks will continue performing in an economic downturn.
Trupanion (NASDAQ: TRUP) offers pet owners insurance plans that give them peace of mind, and that's something for prospective shareholders to wag their tails about. Between its consistent revenue growth and the largely untapped pet insurance market, Trupanion investors might be getting richer for quite some time. In a nutshell, Trupanion takes monthly payments from its subscribers, then uses around 70% of the income to pay the costs for insured pets that need medical care.